Novanta Inc. (NOVT)
NASDAQ: NOVT
· Real-Time Price · USD
121.08
2.22 (1.87%)
At close: May 01, 2025, 3:59 PM
120.81
-0.23%
Pre-market: May 02, 2025, 05:36 AM EDT
Novanta Revenue Breakdown
| Period Ending | Sep 27, 2024 | Mar 29, 2024 | Dec 31, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|
| Medical Solutions Revenue | 103.78M | 102.45M | 80.88M | 83.38M | 83.32M | 77.64M |
| Medical Solutions Revenue Growth | +1.30% | +26.67% | -2.99% | +0.07% | +7.32% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| China Revenue | 73.44M | 97.18M | 95.05M | 70.56M | 59.51M | 66.41M | 56.13M | 44.23M | 14.79M | 10.77M | 51.35M |
| China Revenue Growth | -24.42% | +2.24% | +34.71% | +18.56% | -10.39% | +18.33% | +26.91% | +198.92% | +37.32% | -79.02% | n/a |
| Germany Revenue | 128.23M | 133.73M | 101.86M | 83.77M | 82.03M | 88.03M | 68M | 55.94M | n/a | 58.83M | n/a |
| Germany Revenue Growth | -4.11% | +31.28% | +21.61% | +2.11% | -6.81% | +29.45% | +21.56% | n/a | n/a | n/a | n/a |
| Other Countries Revenue | 19.35M | 18.25M | 10.99M | 9.17M | 11.04M | 7.75M | 10.85M | 18.03M | n/a | 54.31M | n/a |
| Other Countries Revenue Growth | +5.99% | +66.10% | +19.88% | -17.00% | +42.61% | -28.60% | -39.83% | n/a | n/a | n/a | n/a |
| Rest Of Asia Pacific Revenue | 105.35M | 101.6M | 89.2M | 74.33M | 89.59M | 104.3M | 84.73M | 60.1M | n/a | n/a | n/a |
| Rest Of Asia Pacific Revenue Growth | +3.70% | +13.90% | +20.00% | -17.03% | -14.11% | +23.10% | +40.97% | n/a | n/a | n/a | n/a |
| Rest Of Europe Revenue | 137.03M | 137.8M | 138.86M | 127.04M | 129.64M | 105.61M | 81M | 51.7M | n/a | n/a | n/a |
| Rest Of Europe Revenue Growth | -0.56% | -0.76% | +9.31% | -2.01% | +22.76% | +30.38% | +56.66% | n/a | n/a | n/a | n/a |
| United States Revenue | 418.26M | 372.35M | 270.83M | 225.76M | 254.28M | 242.24M | 220.58M | 154.76M | n/a | n/a | n/a |
| United States Revenue Growth | +12.33% | +37.48% | +19.97% | -11.22% | +4.97% | +9.82% | +42.54% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 31, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Dec 31, 2015 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 44.32M | 44.79M | 43.53M | 41.7M | 39.65M | 42.19M | 40.92M | 38.71M | 40.3M | 40.54M | 39.35M | 34.97M | 31.3M | 31.24M | 31.65M | 27.4M | 26.79M | 24.91M | 30.75M | 29.43M | 27.93M | 29.2M | 31.85M | 28.3M | 29.15M | 29.23M | 29.22M | 27.36M | 27.72M | 23.94M | 23M | 19.33M | 20.97M | 20.2M | 21.19M | 19.08M | 19.98M | 20.92M | 22.07M |
| Selling, General, and Administrative Revenue Growth | -1.06% | +2.90% | +4.38% | +5.18% | -6.02% | +3.09% | +5.72% | -3.95% | -0.58% | +3.01% | +12.54% | +11.73% | +0.18% | -1.30% | +15.51% | +2.29% | +7.55% | -19.01% | +4.50% | +5.39% | -4.38% | -8.30% | +12.53% | -2.90% | -0.29% | +0.04% | +6.80% | -1.32% | +15.80% | +4.09% | +18.97% | -7.81% | +3.83% | -4.67% | +11.04% | -4.50% | -4.51% | -5.19% | n/a |
| Research and Development Revenue | 23.25M | 23.73M | 23.25M | 23.45M | 22.02M | 23.38M | 22.83M | 21.9M | 21.35M | 21.59M | 20.93M | 19.42M | 17.47M | 16.95M | 18.68M | 15.99M | 15.23M | 14.44M | 15.33M | 14.77M | 13.81M | 13.39M | 14M | 13.28M | 13.2M | 12.55M | 11.99M | 11.79M | 11.66M | 9M | 9.21M | 7.97M | 7.96M | 8.02M | 8.05M | 7.29M | 7.69M | 7.84M | 8.21M |
| Research and Development Revenue Growth | -2.01% | +2.09% | -0.88% | +6.49% | -5.81% | +2.42% | +4.22% | +2.60% | -1.11% | +3.15% | +7.78% | +11.16% | +3.03% | -9.25% | +16.83% | +4.99% | +5.48% | -5.83% | +3.83% | +6.94% | +3.16% | -4.35% | +5.40% | +0.58% | +5.20% | +4.69% | +1.64% | +1.17% | +29.49% | -2.29% | +15.58% | +0.15% | -0.69% | -0.45% | +10.38% | -5.17% | -1.88% | -4.56% | n/a |